Meeting
2015 ASCO Annual Meeting
Adaptive immune resistance in gastro-esophageal cancer: Correlating tumoral/stromal PDL1 expression with CD8+ cell count.
Authors
Ronan Joseph Kelly
The Sidney Kimmel Comprehensive Cancer Center of Johns Hopkins, Baltimore, MD
Ronan Joseph Kelly , Elizabeth Thompson , Marianna Zahurak , Toby Cornish , Nathan Cuka , Eihab Abdelfatah , Janis M. Taube , Stephen Yang , Mark Duncan , Nita Ahuja , Adrian Murphy , Robert A Anders
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Noncolorectal) Cancer
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Esophageal or Gastric Cancer
Citation
J Clin Oncol 33, 2015 (suppl; abstr 4031)
DOI
10.1200/jco.2015.33.15_suppl.4031
Abstract #
4031
Poster Bd #
140
Abstract Disclosures
Similar Posters
Poster
2016 ASCO Annual Meeting
Tumor-infiltrating CD204+ M2 macrophages compared to T cells as a prognosticator for patients with uterine cervical adenocarcinoma.
First Author: Asuka Kawachi
Poster
2024 ASCO Gastrointestinal Cancers Symposium
A transcriptomic approach to explore the immune landscape of patient with pancreatic ductal adenocarcinoma with prognostic impact.
First Author: Jose Antonio Lopez Guerrero
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Characterization of the cachexia pathway in pancreatic ductal adenocarcinoma.
First Author: Karam Ashouri
Poster
2023 ASCO Annual Meeting
A phase 1 trial of umbilical cord blood–derived tumor-reactive PD-L1+ natural killer cells engineered to express soluble IL-15 (TRACK-NK) in patients with non–small-cell lung cancer (NSCLC) refractory to PD-1/PD-L1 inhibitors.
First Author: Miguel Angel Villalona-Calero